: A A

Archive | Clinical News Room

Even Short-term Oral Steroids Carry Serious Risk

Friday, April 21, 2017

0 Comments

The millions of Americans prescribed short-term oral corticosteroids are taking a dose of risk along with their medication, according to a cohort study of more than 1.5 million adults. Within 30 days of initiating these drugs, even at relatively low doses, users had a nearly twofold increased risk for fracture, a threefold increased risk for […]

Trial of Pregabalin for Acute and Chronic Sciatica

Thursday, March 23, 2017

0 Comments

BACKGROUND Sciatica can be disabling, and evidence regarding medical treatments is limited. Pregabalin is effective in the treatment of some types of neuropathic pain. This study examined whether pregabalin may reduce the intensity of sciatica. METHODS We conducted a randomized, double-blind, placebo-controlled trial of pregabalin in patients with sciatica. Patients were randomly assigned to receive […]

FTC: Homeopathy Products Must Prove Safety and Efficacy

Friday, November 18, 2016

0 Comments

The Federal Trade Commission (FTC) has just announced its intent to pursue manufacturers of over-the-counter (OTC) homeopathy remedies who cannot back up health claims with scientific evidence. Homeopathy products are based on an idea dating from the 1700s that symptoms of disease can be treated by minute doses of substances that produce similar symptoms when […]

INTRANASAL STEROIDS UNDERUSED FOR CHRONIC RHINOSINUSITIS

Monday, September 12, 2016

0 Comments

NEW YORK (Reuters Health) – Topical intranasal steroid therapy is underused in patients with chronic rhinosinusitis despite consistent recommendations supporting it, researchers from Canada report. “The most surprising finding is the low level of utilization for topical steroid therapy despite multiple practice guidelines providing ‘strong recommendation’ for their use in patients with chronic sinusitis,” Dr. […]

Omega-3 From Fish, Plant Sources May Lower Risk of Fatal MI

Monday, July 11, 2016

0 Comments

STANFORD, CA — A pooled study of 19 international cohorts of middle-aged and older people with no prior heart disease found that higher levels of omega-3 polyunsaturated fatty acids (PUFAs) were linked with a lower risk of having a fatal cardiac event within 10 years, but this was not true for nonfatal MI[1]. Specifically, for […]

Positive Long-term Results for Back Pain Procedure

Wednesday, February 24, 2016

0 Comments

PALM SPRINGS, California — A procedure that involves radiofrequency ablation of sensory nerves in the degenerated lumbar disc may give many patients with chronic low back pain significant relief. Researchers have now collected up to 12 months of data on patients undergoing the procedure — called intradiscal biacuplasty (IDB) — and it shows improved pain […]

Three Cups of Coffee a Day Keeps Death Away, Latest Study Shows

Wednesday, November 18, 2015

0 Comments

In the 1500s, health experts warned that coffee could lead to illegal sex. In the 19th century, a hot cup could make you blind, doctors contended. In 2001, java increased your risk of urinary tract cancer. But this morning, at least, your cup of joe can be guilt-free. Moderate coffee drinking reduces mortality rates from […]

Low Vitamin D Linked to Cognitive Decline

Tuesday, September 15, 2015

0 Comments

Low vitamin D levels are very common in older adults, especially African Americans and Hispanics, and are associated with accelerated decline in episodic memory and executive function, the two cognitive domains strongly associated with Alzheimer’s disease (AD) dementia, a new study indicates. “The magnitude of the effect of Vitamin D insufficiency on cognition was substantial,” […]

US clears Sprout Pharmaceuticals’ Addyi as first drug for female sexual desire disorder

Wednesday, August 19, 2015

0 Comments

The FDA on Tuesday cleared Sprout Pharmaceuticals’ once-daily non-hormonal oral drug Addyi (flibanserin) for generalised hypoactive sexual desire disorder (HSDD) in premenopausal women, with the agency noting it is the first FDA-approved drug available to treat sexual desire disorder in either men or women. The decision follows a majority vote by an advisory panel in […]

BioFlorida Annual Conference – October 11-13, 2015 Orlando, FL – Attended

Thursday, July 16, 2015

0 Comments

http://www.bioflorida.com/?page=35